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Rapamycin Attenuates Acute 
Seizure-induced Astrocyte  
Injury in Mice in Vivo
Dongjun Guo, Jia Zou & Michael Wong
Astrocytes have been implicated in epileptogenesis and seizure-induced brain injury. Pathological 
studies reveal a variety of structural abnormalities in astrocytes, such as vacuolization and astrogliosis. 
While in vivo imaging methods have demonstrated rapid changes in astrocytes under a variety of 
physiological and pathological conditions, the acute effects of seizures on astrocyte morphology  
in vivo and corresponding mechanisms of seizure-induced astrocytic injury have not been documented. 
In this study, we utilized in vivo two-photon imaging to directly monitor the acute structural effects of 
kainate-induced seizures on cortical astrocytes. Kainate seizures cause an immediate, but transient, 
vacuolization of astrocytes, followed over several days by astrogliosis. These effects are prevented by 
pre- or post-treatment with rapamycin, indicating the mTOR pathway is involved in mediating seizure-
induced astrocyte injury. These finding have clinical implications for mechanisms of seizure-induced 
astrocyte injury and potential therapeutic applications with mTOR inhibitors.
Astrocytes are a group of specialized glial cells in the central nervous system (CNS). Major roles of astro-
cytes include maintenance of ion and neurotransmitter homeostasis, metabolism, and regulation of synaptic 
development and signaling. Recent evidence indicates that astrocytes are also involved in epileptogenesis and 
seizure-related brain injury1–3. Pathological studies have documented a variety of abnormalities in astrocytes, 
such as astrocyte vacuolization, cell death and astrogliosis, in specimens from human and animal models of epi-
lepsy. In particular, astrogliosis is especially common in epilepsy and is characterized by morphological and func-
tional changes in astrocytes, including hypertrophy of primary processes, variable upregulation of glial fibrillary 
acidic protein (GFAP), and in some cases, increased astrocyte proliferation. Recent advances with in vivo imaging 
have revealed dynamic changes in neurons and glia that were not previously appreciated in pathological studies, 
including rapid effects of seizures on dendritic spines4–6, but the acute effects of seizures on the structure of astro-
cytes are not well documented. Understanding the changes in astrocytes in vivo following seizures could provide 
the opportunity to clarify the specific mechanistic roles of astrocytes in epilepsy and to develop novel therapeutic 
approaches to prevent seizures or their consequences.
Astrocytes have been implicated in promoting epileptogenesis via a diversity of mechanisms, such as increased 
gap junction coupling, impaired glutamate transporter function, and disruption of the blood-brain barrier2. 
Several studies suggest that the mammalian target of rapamycin (mTOR) pathway is activated in astrocytes in 
some types of epilepsy or in animal models7, 8. Other studies show that kainate (KA) induced seizures cause acti-
vation of the mTOR pathway and the mTOR inhibitor, rapamycin, prevents this mTOR activation and reduces 
seizure-induced dendritic injury and subsequent development of epilepsy6, 9. Therefore, mTOR inhibitors, such 
as rapamycin, may also represent a rational and efficacious strategy for preventing astrocyte injury in epilepsy.
In this study, we characterized the rapid, dynamic structural changes in astrocytes in vivo following 
KA-induced seizures utilizing two-photon excitation laser scanning microscopy (2PLSM). We also tested 
the hypothesis that treatment with rapamycin initiated before or after KA-induced seizures (pretreatment or 
post-treatment) has protective effects against seizure-induced astrocyte injury.
Results
KA-induced seizures cause rapid, dynamic morphological changes in astrocytes. In vivo time-
lapse 2PLSM has been utilized to examine the rapid and dynamic structural changes in astrocytes in mouse 
models of stroke and traumatic brain injury10, 11. Here, we used a similar strategy to investigate whether astrocytes 
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undergo rapid, dynamic changes immediately following KA-induced seizures and for a week thereafter. Seizures 
were induced by KA and terminated after 30–45 minutes of cumulative electrographic seizure activity (Fig. 1). 
First of all, under normal physiological conditions, astrocytes maintained a relatively stable number and mor-
phology including astrocyte size, soma size and soma-to-astrocyte ratio, with a bushy appearance and thin 
processes throughout the one week observation period in control mice (Ctrl group; Fig. 2). Mean fluorescence 
intensity (GFAP-driven GFP intensity) also remained stable over time. No obvious astrocyte vacuolization or 
astrogliosis was observed in control mice (Table 1, Fig. 2A–F).
In contrast, KA induced seizures caused acute astrocyte injury characterized initially by vacuolization in ~80% 
astrocytes, followed by astrogliosis (KA group; Fig. 3, Table 1), which was absent in control mice. Astrocyte vac-
uolization occurred immediately after seizures, peaked at 4 hr and persisted up to 3 days but then resolved by one 
week (Fig. 3A–F, Table 1). Between 24 hr to one week after seizures, astrogliosis developed, characterized by an 
increase in GFAP-driven GFP fluorescence intensity (Fig. 3G; p < 0.05 by Kruskal-Wallis test), decrease in astro-
cyte size (Fig. 3I; p < 0.05 by Kruskal-Wallis test) and loss of their classic bushy appearance, with fine individual 
processes becoming more prominent, extensive, and hypertrophied (Fig. 3B–F), without a significant change 
in astrocyte number (Fig. 3H, p > 0.05). Correspondingly, we did not observe any evidence of death of existing 
astrocytes or proliferation of new astrocytes during the 1 wk period after seizures, as evident by a lack of change 
in the number of astrocytes followed individually and serially. The size of the soma also did not change during 
this period (Fig. 3J, p > 0.05) while the ratio of the soma to astrocyte increased at 1 wk after seizures due to the 
decrease in astrocyte size (Fig. 3K, p < 0.05 by one-way ANOVA).
Rapamycin treatment significantly attenuates seizure-induced acute astrocyte injury. Our 
previous studies have demonstrated that rapamycin treatment may attenuate acute dendritic injury caused by 
KA induced seizures6. Therefore, we further tested whether rapamycin treatment would also prevent or rescue 
seizure-induced astrocyte injury. First of all, rapamycin by itself had no significant effect on astrocytes (Rap 
group; Fig. 4). To test the effect of rapamycin on seizure-induced astrocytic changes, two different rapamycin 
Figure 1. Properties of acute KA-induced status epilepticus and lack of effect of rapamycin pre-treatment.  
(A) Representative electrographic seizure following KA injection. (B–E) Rapamycin pre-treatment (6 mg/kg, 
i.p., 48 hr and 24 hr prior to KA) and post-treatment (6 mg/kg i.p., daily for one week, starting immediately after 
seizure termination) have no effect on the properties of seizure latency, number, duration, and severity during 
the acute episode of KA-induced status epilepticus (defined as >30 min of cumulative electrographic seizures). 
(n = 6 per group; One-way ANOVA with Tukey’s test, p > 0.05).
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treatment paradigms, pre- and post-treatment (see Methods), were performed, which have previously been 
demonstrated to inhibit KA-induced mTOR activation and associated dendritic injury6. No significant changes 
in astrocyte number were observed in both the rapamycin pre-treatment (Pre-Rap + KA group, Fig. 5) and 
post-treatment (KA + Post-Rap group, Fig. 6) at all time-points (p > 0.05, by One-way ANOVA with the Tukey’s 
post-test). Furthermore, no significant differences in astrocyte number were observed between the rapamycin 
pre- and post-treatment groups at all time-points, compared to Ctrl, Rap alone, and KA groups (p > 0.05, by 
repeated measures two-way ANOVA with Bonferroni post- test, Fig. 7B).
Importantly, rapamycin pre- and post-treatments were both beneficial in preventing KA seizure-induced 
astrocyte vacuolization, astrogliosis, and astrocyte morphological changes. Rapamycin had no effect on 
KA-induced seizure properties themselves (Fig. 1B–E). However, rapamycin significantly prevented acute 
seizure-induced astrocyte vacuolization immediately after KA induced seizures in the rapamycin pre-treatment 
group (~4% of astrocytes) as well as in the rapamycin post-treatment group (~34% of astrocytes) (Table 1). 
Rapamycin pre-treatment was more beneficial than post-treatment in preventing astrocyte vacuolization. In both 
pre- and post-treatment groups, rapamycin significantly prevented seizure induced astrogliosis and changes in 
mean fluorescence intensity, astrocyte size and the soma-to-astrocyte ratio over the 1 wk period (Fig. 7A,C,E), 
with no significant difference between the two rapamycin treatment groups.
Discussion
In this study, we have documented acute seizure-induced astrocytic injury utilizing in vivo cellular imag-
ing methods and implicated the mTOR pathway in mediating these effects. KA-induced seizures caused acute 
Figure 2. Representative in vivo images of astrocytes and quantitative analysis of astrocyte morphology features 
in the Ctrl group. Under normal physiological conditions, astrocytes typically have a characteristic bushy 
appearance consisting of thin process (A, A1). No obvious astrocytes vacuolization and morphological changes 
(B–F, B1–F1) were observed over a one-week period. No significant changes in mean fluorescence intensity (G), 
astrocyte number (H), astrocyte size (I), soma size (J) and soma-to-astrocyte ratio (K) occurred during a one-
week period. (n = 6; one-way ANOVA or Kruskal-Wallis test, p > 0.05). The arrows in the lower magnification 
images indicate the astrocytes displayed in the higher magnification images.
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vacuolization of astrocytes within a few hours of seizure onset. While the vacuolization recovered over a one 
week period, astrogliosis developed, as characterized by morphological changes and decreased astrocyte size. 
These astrocytic changes were attenuated by rapamycin treatment, supporting the mTOR dependence of this 
seizure-induced astrocytic injury. While seizure-related astrogliosis has been reported previously in pathological 
specimens from animal models and epilepsy patients12–17, the present study is novel in demonstrating very rapid 
effects of seizures on astrocytes, as well as acute effects of rapamycin, with live imaging in vivo.
Although neurons remain the principal cells mediating epilepsy and its comorbidities, the role of glial cells 
in regulating epileptogenesis and associated brain injury has become increasingly recognized. In particular, 
abnormalities in astrocytes have been implicated in promoting epileptogenesis via a diversity of mechanisms, 
including extracellular ion and neurotransmitter homeostasis, immune and inflammatory processes, and 
astrocyte-neuronal synaptic signaling1–3. Furthermore, astrocytic death, gliosis, or other structural changes in 
astrocytes are commonly identified in pathological specimens from animal models and patients with epilepsy12–17. 
In contrast to the fixed, static view provided by conventional pathological studies, recent advances with time-lapse 
imaging of living tissue demonstrate that astrocytes undergo rapid, dynamic structural changes under a variety of 
physiological and pathological conditions, including neuronal activity-dependent modulation10, 18–21. This rapid 
motility of astrocytes may directly affect neuronal function, such as by modulating the plasticity of synapses and 
dendritic spines18, 19. The present study is significant in demonstrating for the first time that seizures themselves 
can cause immediate vacuolization of astrocyte in vivo, followed by more gradual development of astrogliosis. 
While the vacuolization was reversible within a few days, the astrogliosis persisted at a week after seizures and 








 Pre-seizure 107 107 (100%) 0 (0%)
  *0 hr 107 107 (100%) 0 (0%)
  *4 hr 107 107 (100%) 0 (0%)
  *24 hr 107 107 (100%) 0 (0%)
  *3 d 107 107 (100%) 0 (0%)
  1 wk 107 107 (100%) 0 (0%)
Rap
 Pre-seizure
  *0 hr 118 118 (100%) 0 (0%)
  *4 hr 118 118 (100%) 0 (0%)
  *24 hr 118 118 (100%) 0 (0%)
  *3 d 118 118 (100%) 0 (0%)
  1 wk 118 118 (100%) 0 (0%)
KA
 Pre-seizure 106 106 (100%) 0 (0%)
  0 hr 106 26 (24.5%) 80 (75.5%)
  4 hr 106 23 (21.7%) 83 (78.3%)
  24 hr 106 71 (67.0%) 35 (33.0%)
  3 d 106 82 (77.4%) 24 (22.6%)
  1 wk 106 106 (100%) 0 (0%)
Pre-Rap + KA
 Pre-seizure 107 107 (100%) 0 (0%)
  *0 hr 107 103 (96.3%) 4 (3.7%)
  *4 hr 107 103 (96.3%) 4 (3.7%)
  *24 hr 107 104 (97.2%) 3 (2.8%)
  *3 d 107 107 (100%) 0 (0%)
  1 wk 107 107 (100%) 0 (0%)
KA + Post-Rap
 Pre-seizure 89 89 (100%) 0 (0%)
  *0 hr 89 59 (66.3%) 30 (33.7%)
  *4 hr 89 60 (67.4%) 29 (32.6%)
  24 hr 89 66 (74.2%) 23 (25.8%)
  *3 d 89 81 (91.0%) 8 (9.0%)
  1 wk 89 89 (100%) 0 (0%)
Table 1. Effect of rapamycin treatment on kainate seizure induced astrocyte vacuolization. *p < 0.05 vs. KA by 
Chi-square.
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Astrocytic vacuolization has primarily been associated with irreversible astrocytic injury or death in a process 
termed “clasmatodendrosis”. The mechanisms of astrocytic vacuolization remain incompletely defined, but one 
recent study suggests that F-actin depolymerization accelerates astrocytic vacuolization following pilocarpine 
induced status epilepticus model via activation of lysosome-derived autophagic mechanisms, and F-actin stabi-
lizer infusion significantly decreases the size and number of the vacuoles in astrocytes22. Another study has shown 
that reduction of MLC1 protein levels causes vacuolization in astrocytes23, which may be linked to abnormal 
cellular ionic and water transport. However, previous studies were based on fixed tissue and documented changes 
over relatively long time courses, which may miss rapid dynamic changes of astrocytes after acute injury. In this 
study, utilizing in vivo cellular imaging methods, we documented an acute, reversible vacuolization of astrocytes 
following KA-induced seizures. This vacuolization occurred within a few hours of seizure onset, and reversed 
over a one-week period. Further studies are needed to determine the functional consequences of this acute vacu-
olization and its relationship to more classic, chronic astrocytic injury.
In the present study, we also found that reactive astrogliosis developed within several days after KA-induced 
seizures, as evident by morphological changes and upregulated GFAP expression. Reactive astrogliosis is another 
important pathological marker in the epileptic brain in animal models and in human patients, and may contribute 
to epileptogenesis by a variety of mechanisms1–3. While hypertrophy of the primary processes occurred following 
Figure 3. Representative in vivo images of astrocytes and quantitative analysis of astrocyte morphology features 
in the KA group. KA induced seizures caused acute astrocyte injury including vacuolization in most astrocytes 
followed by astrogliosis (B-F, B1–F1). Vacuolization of astrocytes occurred immediately after seizures, 
peaked at 4 hr and persisted up to 3 days (arrow head in C1). One week after seizures, astrogliosis developed, 
characterized by a decrease in astrocyte size and loss of their classic bushy appearance, with fine individual 
processes becoming more prominent and extensive (F, F1). No significant proliferation of new astrocytes 
was observed. However, mean fluorescence intensity increased at 4 hr, 24 hr, 3 d and 1 wk after seizures (G). 
Astrocyte size decreased significantly at 1 wk after seizures (I) and the soma-to-astrocyte ratio increased at 1 wk 
when compared to pre-seizure (J) (n = 6; *p < 0.05 compared with pre, by Kruskal-Wallis test with Dunns post-
test). The arrows in the lower magnification images indicate the astrocytes displayed in the higher magnification 
images.
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KA-induced seizures, the apparent overall astrocyte size appeared to decrease. Although astrocyte hypertrophy is 
often thought as a hallmark of astrogliosis, some studies suggest that reactive astrocytes increase the thickness of 
their main cellular processes but maintain a restricted overall distribution and volume24. The acute in vivo imag-
ing from the present study helps define the initial time course and evolution of specific morphological changes to 
astrocytes, reflective of astrogliosis following status epilepticus.
The molecular mechanisms of seizure-induced astrocytic injury are still incompletely understood. The mech-
anisms driving astrogliosis itself is somewhat controversial, but likely involves altered expression of a number 
of genes and proteins, leading to both structural and functional changes in astrocytes25. The mTOR pathway 
is a master regulator of a large multitude of proteins and is activated in astrocytes in animal models following 
seizures and in brain specimens of epilepsy patients26, 27. It is plausible that seizure-induced activation of mTOR 
within astrocytes can upregulate a cascade of downstream proteins that are involved in astrogliosis. A recent 
study indicates that genetic deletion of mTOR decreases chronic astrogliosis and seizures in the kainate model28. 
Consistent with this study, we find that pharmacological inhibition of mTOR with rapamycin also reduces acute 
seizure-induced astrocytic injury and astrogliosis. Rapamycin has previously been shown to reduce astrocyte 
proliferation or astrogliosis in other non-seizure models of central nervous system injury29, 30. We have also pre-
viously shown that rapamycin can reduce seizure-induced dendritic spine injury6. Thus, in addition to the mech-
anistic implications of these findings, there are potential clinical applications of the use of mTOR inhibitors to 
prevent seizure-induced brain injury, including both neurons and astrocytes.
Finally, the functional consequences of this acute astrocytic injury are not known, but it is reasonable to 
hypothesize that seizure-induced astrocytic changes may directly relate to synaptic and dendritic injury following 
Figure 4. Representative in vivo images of astrocytes and quantitative analysis of astrocyte morphology features 
in the Rap group. Astrocytes typically have a characteristic bushy appearance consisting of thin processes  
(A, A1). No obvious astrocytes vacuolization and morphological changes (B–F, B1–F1) were observed over a 
one-week period. No significant changes in mean fluorescence intensity (G), astrocyte number (H), astrocyte 
size (I), soma size (J) and soma-to-astrocyte ratio (K) occurred during a one-week period. (n = 6; one-way 
ANOVA or Kruskal-Wallis test with Dunns post-test, p > 0.05). The arrows in the lower magnification images 
indicate the astrocytes displayed in the higher magnification images.
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seizures, which have similarly been documented with in vivo imaging studies and are reversible with mTOR 
inhibitors4–6. Astrocytes help support and maintain the structural integrity and functionality of synapses, espe-
cially of dendritic spines18, 19. Collectively, the seizure-induced injury to both astrocytes and neurons could pro-
mote progressive epileptogenesis or contribute to cognitive and other neurological deficits in epilepsy patients. 
Preventative approaches, targeting either seizure-induced astrocyte or neuronal injury, may be effective for alle-
viating the negative consequences of epilepsy.
Materials and Methods
Animals. Two-to-three month old GFAP-GFP transgenic mice expressing enhanced green fluorescent protein 
(GFP) under a GFAP promoter were used for all experiments31. Care and use of animals were approved by the 
Washington University School of Medicine Animal Studies Committee and followed guidelines from the National 
Institutes of Health Guide for the Care and Use of Laboratory Animals.
Surgery. Animal surgeries were performed using aseptic procedures as previously reported6, 31. Briefly, mice 
were anesthetized with isoflurane and held in a custom-made stereotaxic device, which could be mounted to 
the microscope stage. A heating pad was used to maintain body temperature while under anesthesia. The skull 
(a round area of ~2 mm in diameter) was carefully thinned to leave about 20 µm of the inner cortical bone. The 
thinned skull was coated with a layer of cyanoacrylate glue (Krazy Glue, Elmer’s Products) and then covered with 
a glass coverslip (#1 in thickness, 5 mm in diameter) over the thinned-skull (Supplemental Fig. 1A). Three screw 
electrodes were placed adjacent to the cranial window to record electroencephalography (EEG). Cyanoacrylate 
Figure 5. Representative in vivo images of astrocytes and quantitative analysis of astrocyte morphology 
features in the Pre-Rap + KA group. With rapamycin pre-treatment, the astrocytes reserved the normal bushy 
appearance after KA induced seizures. No obvious morphological change, vacuolization and astrogliosis were 
observed in most astrocytes (A–F, A1–F1). The mean fluorescence intensity, astrocyte number, astrocyte size, 
soma size and soma-to-astrocyte ratio did not change over a one-week period (G–K) (n = 6; one-way ANOVA 
or Kruskal-Wallis test with Dunns post-test, p > 0.05). The arrows in the lower magnification images indicate 
the astrocytes displayed in the higher magnification images.
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glue and dental cement (SNAP, Parkwell inc) were applied around the edges of the coverslip to stabilize the cov-
erslip and the EEG electrodes to the skull.
Seizure induction and electroencephalogram recording. After obtaining baseline astrocytes images, 
the mice were allowed to recover from anesthesia, and EEG data were acquired simultaneously. EEG signals were 
amplified and filtered (1–100 Hz) using Powerlab PL3508 amplifiers (AD Instruments, Colorado Springs, CO) 
and digitized (200 Hz) with LabChart (AD Instruments, Colorado Springs, CO). Mice were then injected with 
KA (Sigma, St. Louis, MO) (20 mg/kg, i.p., KA group) to induce seizures. Control mice received saline injec-
tion instead of KA (Ctrl group). Electrographic seizures were recorded by EEG and the cumulative duration of 
individual seizures was monitored. An individual seizure was defined as a discrete epoch of repetitive spikes or 
spike-and-wave discharges lasting at least 10 seconds (Fig. 1A). The behavioral correlate of seizures was scored 
using a modified Racine scale5: stage 1 – behavioral arrest with mouth/facial movements, stage 2 – head nodding, 
stage 3 – forelimb clonus, stage 4 – rearing, stage 5 – rearing and falling, stage 6 – loss of posture, and generalized 
convulsive activity. Seizure latency, number, score, and total seizure duration during the acute episode of status 
epilepticus (defined as >30 min of cumulative seizures) were calculated and analyzed, as described previously6. 
After a cumulative 30–45 min duration of electrographic seizures, seizures were terminated by isoflurane anes-
thesia induction for subsequent post-seizure imaging at 0 and 4 h. The mice were then housed and followed with 
post-seizure time-lapse imaging for 1 week.
Figure 6. Representative in vivo images of astrocytes and quantitative analysis of astrocyte morphology 
features in the KA + Post-Rap group. With rapamycin post-treatment, most astrocytes present the similar bushy 
appearance with fine processes as pre-seizure’s condition. No obvious morphological change, vacuolization 
and astrogliosis were observed in most astrocytes (A–F, A1–F1). Compared to pre-seizure condition, mean 
fluorescence intensity, astrocyte number, astrocyte size, soma size and soma-to-astrocyte ratio did not change 
over a one-week period (G–K) (n = 6; one-way ANOVA or Kruskal-Wallis test with Dunns post-test, p > 0.05). 
The arrows in the lower magnification images indicate the astrocytes displayed in the higher magnification 
images.
www.nature.com/scientificreports/
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Rapamycin treatment. Rapamycin (LC Labs, Woburn, MA, USA) was initially dissolved in 100% ethanol 
(30 mg/mL), stored at −20 °C, and diluted (1:10) in a vehicle solution containing 5% Tween 80, 5% PEG 400 
(low-molecular-weight grade of polyethylene glycol), and 4% ethanol immediately before injection. All other 
chemicals were obtained from Sigma unless indicated otherwise. Two different rapamycin treatment paradigms 
were performed in this study, based on previous studies demonstrating inhibitory effects of rapamycin on KA 
seizure-induced mTOR activation6. For a pre-treatment study, rapamycin (6 mg/kg, i.p.) was administered 48 
and 24 h before KA injection (Pre-Rap + KA group). For a post-treatment study, rapamycin (6 mg/kg, i.p.) was 
administrated daily for up to 1 week, starting immediately after KA-induced status epilepticus was terminated 
(KA + Post-Rap group) and mice were followed up for imaging at various times points (0 h defined as immedi-
ately after seizure termination and rapamycin administration). Both studies also included two control groups of 
mice without KA-induced seizures injected with saline (Ctrl) or rapamycin (Rap).
Two-photon imaging. Baseline images of astrocytes in neocortex were obtained through the thinned skull 
using a two-photon microscope (LSM 510; Zeiss, Thornwood, NY) with a water immersion objective (Zeiss, 40x, 
Figure 7. Quantitative analysis of effect of rapamycin treatment on KA seizures induced fluorescence intensity, 
astrocyte number and morphological changes (astrocyte size, soma size and soma-to-astrocyte ratio) over 
a one-week period. (A) Changes in mean fluorescence intensity over a one-week period in Ctrl, Rap, KA, 
Pre-Rap + KA, and KA + Post-Rap groups. Starting from 4 hr after KA seizures, mean fluoroscence intensity 
increased significantly in KA group when compared to Ctrl, Rap, Pre-Rap + KA, and KA + Post-Rap groups. 
Both rapamycin pre- and post- treatment reversed the increase in fluorescence intensity. (*p < 0.05 compared 
with KA at 4 hr, 24 hr, 3 d and 1 wk, by repeated measures two-way ANOVA with Bonferroni posttests).  
(B) Changes of astrocyte number over a one-week period in Ctrl, Rap, KA, Pre-Rap + KA, and KA + Post-Rap 
groups. There is no significant difference among the five groups in astrocytes number at all observed time-
points (p > 0.05, by repeated measures two-way ANOVA with Bonferroni post-test). (C) Changes of astrocyte 
size during a one-week period in Ctrl, Rap, KA, Pre-Rap + KA, and KA + Post-Rap groups. Compared to Ctrl, 
Rap, Pre-Rap + KA, and KA + Post-Rap groups, astrocyte size decreased significantly at 1 wk after seizures in 
KA group. Both rapamycin pre- and post- treatment reversed the decrease of astrocyte size at 1 wk after seizures 
(*p < 0.05 compared with KA at 1 wk, by repeated measures two-way ANOVA with Bonferroni post-test).  
(D) Changes of soma size over a one-week period in Ctrl, Rap, KA, Pre-Rap + KA, and KA + Post-Rap groups. 
There is no significant difference among five groups in soma size at all observed time-points (p > 0.05, by 
repeated measures two-way ANOVA with Bonferroni post-test). (E) Changes of the ratio of soma-to-astrocyte 
during a one-week period in Ctrl, Rap, KA, Pre-Rap + KA, and KA + Post-Rap groups. The ratio decreased 
significantly in KA group when compared to Ctrl, Rap, Pre-Rap + KA, and KA + Post-Rap groups at 1 wk after 
seizures. Both rapamycin pre- and post-treatment reversed the ratio of soma-to-astrocyte at 1 wk after seizures 
(*p < 0.05 compared to KA at 1 wk by repeated measures two-way ANOVA with Bonferroni post-test).
www.nature.com/scientificreports/
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0.8 numerical aperture (NA), IR-adjusted, Zeiss), as previously described31. A Titanium-Sapphire pulsed infrared 
laser (Coherent, Santa Clara, CA) was used to stimulate GFP at 900 nm. Low-magnification images approximately 
50 to 100 μm below the neocortical surface were first obtained to identify regions with GFP positive astrocytes. At 
higher magnification (3x digital zoom), z-stacks of 6 to 10 images with 1 μm steps were taken. Individual images 
were acquired at 12 bits with frame averaging (2–4 times). The same excitation laser power and acquisition set-
tings (e.g., detection gain, amplifier offset, amplifier gain) were maintained in individual animals at different time 
points for direct comparison. Following seizures, the surface vasculature pattern was used to identify the same 
astrocytes for post-seizure time-lapse imaging at various times (0 h, 4 h, 24 h, 3 days and 1 week) (Supplemental 
Fig. 1B). Mice were excluded from analysis due to dura damage, excessive bleeding, or obvious opacity of the 
initial baseline images. All mice included for analysis were successfully followed for one week observation (n = 6 
mice per group).
Post hoc image analysis. Post hoc image analysis was performed using LSM 5 Image Examiner software 
(Zeiss) and Image J software (NIH) in a blinded fashion to evaluate the changes in fluorescence intensity, astro-
cyte number, and morphological features of astrocytes (astrocyte size, soma size, soma-astrocyte-ratio, astrocyte 
vacuolization) over time. A standard area of 150 µm × 150 µm was chosen as the region of interested (ROI) for 
each mouse, and the same ROI was analyzed at different time points. Astrocyte number was counted in the same 
ROI at different time points. The fluorescence intensity (GFAP-driven GFP intensity), astrocyte size and soma size 
at different time points after the seizures were normalized to those at baseline before the seizures in each group. 
Morphological features of astrocytes were assessed with respect to total astrocyte size (including processes) and 
soma size, based on area calculations from the projected Z-stacks using ImageJ software. To measure the area of 
astrocyte soma (excluding branches/fine processes) and total area, lines were drawn as described previously31. In 
addition to surface area measurements, the vacuolization of astrocytes was also recorded. A vacuole was defined 
as diameter bigger than 0.5 µm and was clearly seen in the astrocyte.
Statistics. Statistical analysis was performed using GraphPad Prism 5 software. One-way analysis of variance 
(ANOVA) with Tukey’s multiple comparison was used for parametric comparisons of astrocyte number and 
soma-to-astrocyte ratio, as well as seizure parameters (latency, number, duration, score). Kruskal-Wallis test with 
Dunns posttest was used for non-parametric comparisons of mean fluorescence intensity, astrocyte size and soma 
size. Repeated measures two-way analysis of variance (ANOVA) with Bonferroni post tests for multiple compar-
isons was used to compare changes in fluorescence intensity, astrocyte number, the size of astrocyte and its soma, 
and soma-to-astrocyte ratio between different groups. Chi-square test of independence was used to compare 
the distribution of astrocytes vacuolization between different groups. All data are expressed as mean ± SEM. 
Statistical significance was defined as P < 0.05.
Data Availability Statement. The datasets generated during and/or analysed during the current study are 
available from the corresponding author on request.
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